Implementation of a Pharmacist-Led, Multidisciplinary Naloxone Patient Education Program at an Academic Medical Center

J Pharm Pract. 2023 Oct;36(5):1201-1210. doi: 10.1177/08971900221094268. Epub 2022 Apr 28.

Abstract

Background: Opioid related overdoses are a leading cause of death in the United States (U.S). National, state and local initiatives have been implemented to combat the opioid crisis. However, there is a paucity of initiatives that examine the role of comprehensive naloxone education interventions for hospitalized patients. Objective: The aim of this study was to design a multidisciplinary, pharmacist-driven, standardized, patient and product tailored, inpatient naloxone education program (NEP) at a U.S. academic medical center, targeting patients at high risk of opioid overdose, and to examine patients' retention of education. Methods: This prospective pilot study targeted hospitalized patients who were considered at high-risk for opioid overdose once discharged. Using daily screening methods and established inclusion criteria, we evaluated the impact of implementing a patient-tailored NEP. The primary outcome measures were patient knowledge and awareness of naloxone use. A paired t-test analysis was conducted to assess for improvement in patient naloxone awareness and knowledge. Results: Of ninety-five patients screened, forty-four patients met inclusion criteria and nineteen patients completed naloxone education along with pre- and post-assessments. Patients more accurately completed the assessment, indicating enhanced knowledge about naloxone use and administration, following the naloxone education (4.68 ± .13 vs 3.42 ± .31 out of 5 questions, mean ± SEM; P = .0016). Conclusion: This study found a positive impact on patient knowledge of naloxone use and administration following implementation of a robust and comprehensive NEP.

Keywords: education; naloxone; opioid; overdose; pharmacist.

MeSH terms

  • Academic Medical Centers
  • Analgesics, Opioid / adverse effects
  • Drug Overdose* / drug therapy
  • Drug Overdose* / prevention & control
  • Humans
  • Naloxone / therapeutic use
  • Narcotic Antagonists / therapeutic use
  • Opiate Overdose* / drug therapy
  • Opioid-Related Disorders* / drug therapy
  • Patient Education as Topic
  • Pharmacists
  • Pilot Projects
  • Prospective Studies
  • United States

Substances

  • Naloxone
  • Narcotic Antagonists
  • Analgesics, Opioid